This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Trost, T. M. Articles by Spangenberg, C. Search for Related Content PubMed PubMed Citation Articles by Trost, T. M. Articles by Spangenberg, C.

Premature Senescence Is a Primary Fail-safe Mechanism of ERBB2-Driven Tumorigenesis in Breast Carcinoma Cells

¹ Children's Hospital, ² FACS Core Facility, ³ Laboratory of Molecular Mouse Genetics, Institute of Toxicology, and ⁴ Institute of Toxicology, University of Mainz, Mainz, Germany; and ⁵ Center for Toxicology, Institute of Legal Medicine and Rudolf-Boehm Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany

Requests for reprints: Christian Spangenberg, Children's Hospital University of Mainz, Obere Zahlbacher Strasse 63, 55131 Mainz, Germany. Phone: 49-6131-3933339; Fax: 49-6131-3930227; E-mail:spange{at}molgen.medizin.uni-mainz.de.

The receptor tyrosine kinase ERBB2 plays a central role in the development of breast cancer and other epithelial malignancies. Elevated ERBB2 activity is believed to transform cells by transmitting mitogenic and antiapoptotic signals. Here we show that tightly regulated overexpression of oncogenic ERBB2 in human breast carcinoma cells does not stimulate proliferation but provokes premature senescence, accompanied by up-regulation of the cyclin-dependent kinase inhibitor P21^WAF1/CIP1. A similar effect was caused by retrovirus-mediated overexpression of oncogenic ERBB2 in low-passage murine embryonic fibroblasts. In contrast to previous observations based on constitutively overexpressing cell lines, P21 induced by tetracycline-regulated ERBB2 localizes to the nucleus in arrested cells. P21 up-regulation seems to be independent of the P53 tumor suppressor protein, and senescence-associated phenotypic alterations are reversed by specific inhibition of P38 mitogen-activated protein kinases. Functional inactivation of P21 by antisense oligonucleotides is sufficient to prevent cell cycle arrest as well as the senescent phenotype, thereby identifying the P21 protein as the key mediator of hypermitogenic cell cycle arrest and premature senescence in breast carcinoma cells. Our results may thus indicate that premature senescence represents an inherent anticarcinogenic program during ERBB2-driven mammary tumorigenesis. We propose a multistep model for the process of malignant transformation by ERBB2 wherein secondary lesions either target P21 or downstream effectors of senescence to bypass this primary fail-safe mechanism.

Key Words: ERBB2 • tumorigenesis • premature senescence • P21 • Tet system

This article has been cited by other articles:

				I. B. Petry, E. Fieber, M. Schmidt, M. Gehrmann, S. Gebhard, M. Hermes, W. Schormann, S. Selinski, E. Freis, H. Schwender, et al. ERBB2 Induces an Antiapoptotic Expression Pattern of Bcl-2 Family Members in Node-Negative Breast Cancer Clin. Cancer Res., January 15, 2010; 16(2): 451 - 460. [Abstract] [Full Text] [PDF]

				L. Lopez-Vicente, G. Armengol, B. Pons, L. Coch, E. Argelaguet, M. Lleonart, J. Hernandez-Losa, I. de Torres, and S. Ramon y Cajal Regulation of Replicative and Stress-Induced Senescence by RSK4, which is Down-regulated in Human Tumors Clin. Cancer Res., July 15, 2009; 15(14): 4546 - 4553. [Abstract] [Full Text] [PDF]

				D. Su, S. Zhu, X. Han, Y. Feng, H. Huang, G. Ren, L. Pan, Y. Zhang, J. Lu, and B. Huang BMP4-Smad Signaling Pathway Mediates Adriamycin-induced Premature Senescence in Lung Cancer Cells J. Biol. Chem., May 1, 2009; 284(18): 12153 - 12164. [Abstract] [Full Text] [PDF]

				T. E. Strecker, Q. Shen, Y. Zhang, J. L. Hill, Y. Li, C. Wang, H.-T. Kim, T. M. Gilmer, K. R. Sexton, S. G. Hilsenbeck, et al. Effect of Lapatinib on the Development of Estrogen Receptor-Negative Mammary Tumors in Mice J Natl Cancer Inst, January 21, 2009; 101(2): 107 - 113. [Abstract] [Full Text] [PDF]

				H. Chen, J. S. Lee, X. Liang, H. Zhang, T. Zhu, Z. Zhang, M. E. Taylor, C. Zahnow, L. Feigenbaum, A. Rein, et al. Hoxb7 Inhibits Transgenic HER-2/neu-Induced Mouse Mammary Tumor Onset but Promotes Progression and Lung Metastasis Cancer Res., May 15, 2008; 68(10): 3637 - 3644. [Abstract] [Full Text] [PDF]

				J. Campisi Protumorigenic Effects of the Senescence-Associated Secretory Phenotype Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 505 - 509. [Abstract] [Full Text] [PDF]

				A. Swarbrick, E. Roy, T. Allen, and J. M. Bishop Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response PNAS, April 8, 2008; 105(14): 5402 - 5407. [Abstract] [Full Text] [PDF]

				G. Shyamala, Y.-C. Chou, R. D. Cardiff, and E. Vargis Effect of c-neu/ ErbB2 Expression Levels on Estrogen Receptor {alpha}-Dependent Proliferation in Mammary Epithelial Cells: Implications for Breast Cancer Biology Cancer Res., November 1, 2006; 66(21): 10391 - 10398. [Abstract] [Full Text] [PDF]

				C. Spangenberg, E. U. Lausch, T. M. Trost, D. Prawitt, A. May, R. Keppler, S. A. Fees, D. Reutzel, C. Bell, S. Schmitt, et al. ERBB2-Mediated Transcriptional Up-regulation of the {alpha}5{beta}1 Integrin Fibronectin Receptor Promotes Tumor Cell Survival Under Adverse Conditions. Cancer Res., April 1, 2006; 66(7): 3715 - 3725. [Abstract] [Full Text] [PDF]

				J. G. Hodgson, T. Malek, S. Bornstein, S. Hariono, D. G. Ginzinger, W. J. Muller, and J. W. Gray Copy Number Aberrations in Mouse Breast Tumors Reveal Loci and Genes Important in Tumorigenic Receptor Tyrosine Kinase Signaling Cancer Res., November 1, 2005; 65(21): 9695 - 9704. [Abstract] [Full Text] [PDF]